Tags » Neuroprotection

The dilemma of success

Late last year, I wrote a post for Parkinson’s UK‘s excellent blog on Medium.

My piece was called the Dilemma of Success, and it explored a hypothetical situation that we may very well face in the not-so-distant future. 1,839 more words

New Drug Compounds Help Prevent Hearing Loss

Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. 389 more words

Parkinson's disease: cannabidiol, tetrahydrocannabinol, CB1 and CB2 receptors and anti-oxidant properties in neuroprotection 

Virginia Thornley, M.D., Neurologist, Epileptologist

March 2, 2018

Introduction

Cannabinoids are compounds part of the endocannabinoid pathways found inherent to the brain comprising of endocannabinoids, transporters and receptors. 548 more words

CB1 Receptor

Lancet Neurology - Special Issue Dedicated to TBI

I realise that this is old news by now, but I´ve somehow neglected to put out this excellent collection of articles on NeuroScand. The November issue of Lancet Neurology is dedicated in its entirety to traumatic brain injury and features a number of inspiring and thought-provoking editorials. 6 more words

Traumatic Brain Injury

EDITOR’S CHOICE – Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids – Current Neuropharmacology

Journal: Current Neuropharmacology

Author(s): Elzbieta Rebas, Tomasz Radzik, Tomasz Boczek, Ludmila Zylinska

Graphical Abstract:

Abstract:

Background: Neurosteroids form the unique group because of their dual mechanism of action. 246 more words

Bentham Science Publishers

TTM - New Guidelines from NCS

Targeted temperature management (TTM) as a neuroptotective strategy is applied in a number of scenarios; post-ROSC in cardiac arrest, neonatal asphyxia, traumatic brain injury, to name some. 89 more words

Traumatic Brain Injury